Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt
Ke-Neng Chen, MDIn a two-part commentary, Dr. Ke-Neng Chen discusses how surgeons must adjust in light of recent clinical trials, beginning with a discussion of the challenges of TNM staging. Read more
More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care
Ke-Neng Chen, MDAs thoracic surgery in the management of NSCLC evolves, Dr. Ke-Neng Chen highlights the importance of avoiding unnecessary treatments and using a multidisciplinary approach. Read more
A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib
Narjust Florez, MDIn part 2 of their interview, Drs. Narjust Florez and Benjamin Solomon dig deeper into the implications of the ALINA trial, discussing endpoints, toxicities, and future directions. Read more
European Commission OKs Tislelizumab for NSCLC
Erin JungmeyerIn other regulatory news, the US FDA recently granted a Breakthrough Therapy Designation for sunvozertinib for first-line treatment of advanced non-small cell lung cancer with EGFR Exon 20 Insertion mutations. Read more
Submit abstracts for ACLC 2024 by June 7, register for the 2024 CT Screening Symposium, and contribute memories for the 50th anniversary time capsule. Read more
Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine
Christian Rolfo, MD, PhD, MBA, Drhc+more
Drs. Christian Rolfo and Valeria Denninghoff contend that data show improvements in outcomes from personalized treatment may have stalled and that increased testing for driver genes alterations is needed. Read more
Adjuvant Alectinib for ALK+ NSCLC: An Interview with Dr. Benjamin Solomon
Narjust Florez, MDSpeaking with Dr. Narjust Florez, Prof. Solomon discusses the design and results of the ALINA trial. Read more
The US approved alectinib as adjuvant treatment based on a significant DFS benefit compared to chemotherapy. Read more
Could Precision Oncology Evolve to Treat Cancer Before It Develops?
Laila C. Roisman, PhD+more
Drs. Laila Roisman and Nir Peled envision a future where artificial intelligence elevates personalized medicine in ways once thought impossible. Read more
Stark Contrast in Recent Tobacco Control Laws Worldwide
Erin JungmeyerThe UK recently moved to ban smoking for individuals born after 2009 while the US delayed implementation of a ban on menthol cigarettes—again. Read more